178 related articles for article (PubMed ID: 32638384)
1. Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real-life data.
Hamers PAH; Elferink MAG; Stellato RK; Punt CJA; May AM; Koopman M; Vink GR
Int J Cancer; 2021 Jan; 148(2):296-306. PubMed ID: 32638384
[TBL] [Abstract][Full Text] [Related]
2. Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: a systematic review of randomised trials.
West TA; Kiely BE; Stockler MR
Eur J Cancer; 2014 Jul; 50(11):1916-24. PubMed ID: 24825113
[TBL] [Abstract][Full Text] [Related]
3. How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials.
Kiely BE; Soon YY; Tattersall MH; Stockler MR
J Clin Oncol; 2011 Feb; 29(4):456-63. PubMed ID: 21189397
[TBL] [Abstract][Full Text] [Related]
4. Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapy.
Smith-Uffen M; Park J; Parsonson A; Kiely BE; Vasista A
Oncologist; 2024 May; ():. PubMed ID: 38768122
[TBL] [Abstract][Full Text] [Related]
5. Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry.
Tomita Y; Karapetis CS; Ullah S; Townsend AR; Roder D; Beeke C; Roy AC; Padbury R; Price TJ
Acta Oncol; 2016; 55(4):480-5. PubMed ID: 26878155
[TBL] [Abstract][Full Text] [Related]
6. More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials.
Vasista A; Stockler MR; West T; Wilcken N; Kiely BE
Breast; 2017 Feb; 31():99-104. PubMed ID: 27829202
[TBL] [Abstract][Full Text] [Related]
7. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases.
van der Geest LG; Lam-Boer J; Koopman M; Verhoef C; Elferink MA; de Wilt JH
Clin Exp Metastasis; 2015 Jun; 32(5):457-65. PubMed ID: 25899064
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
9. Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: a systematic review of contemporary randomized trials.
Kiely BE; Alam M; Blinman P; Tattersall MH; Stockler MR
Lung Cancer; 2012 Sep; 77(3):537-44. PubMed ID: 22609149
[TBL] [Abstract][Full Text] [Related]
10. Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004.
Meulenbeld HJ; van Steenbergen LN; Janssen-Heijnen ML; Lemmens VE; Creemers GJ
Ann Oncol; 2008 Sep; 19(9):1600-4. PubMed ID: 18467312
[TBL] [Abstract][Full Text] [Related]
11. Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in the Netherlands.
't Lam-Boer J; Van der Geest LG; Verhoef C; Elferink ME; Koopman M; de Wilt JH
Int J Cancer; 2016 Nov; 139(9):2082-94. PubMed ID: 27342618
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors, treatment, and survival of ovarian metastases of colorectal origin: a Dutch population-based study.
Bakkers C; van der Meer R; Roumen RM; Lurvink RJ; Lemmens VE; van Erning FN; de Hingh IH
Int J Colorectal Dis; 2020 Jun; 35(6):1035-1044. PubMed ID: 32157379
[TBL] [Abstract][Full Text] [Related]
13. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis.
Sakin A; Sahin S; Atci MM; Yasar N; Geredeli C; Aribal S; Alemdar A; Karataş F; Cihan S
J BUON; 2019; 24(5):1801-1808. PubMed ID: 31786840
[TBL] [Abstract][Full Text] [Related]
15. Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: A population-based study.
Kuijper SC; Pape M; Vissers PAJ; Jeene PM; Kouwenhoven EA; Haj Mohammad N; Ruurda JP; Sosef MN; Verhoeven RHA; van Laarhoven HWM
Int J Cancer; 2023 Jul; 153(1):33-43. PubMed ID: 36855965
[TBL] [Abstract][Full Text] [Related]
16. Beyond Median Overall Survival: Estimating Trends for Multiple Survival Scenarios in Patients With Metastatic Esophagogastric Cancer.
Pape M; Kuijper SC; Vissers PAJ; Beerepoot LV; Creemers GJ; van Laarhoven HWM; Verhoeven RHA
J Natl Compr Canc Netw; 2022 Dec; 20(12):1321-1329.e4. PubMed ID: 36509070
[TBL] [Abstract][Full Text] [Related]
17. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry.
Chong LC; Townsend AR; Young J; Roy A; Piantadosi C; Hardingham JE; Roder D; Karapetis C; Padbury R; Maddern G; Moore J; Price TJ
Target Oncol; 2019 Feb; 14(1):85-91. PubMed ID: 30659494
[TBL] [Abstract][Full Text] [Related]
18. A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.
Kumar R; Jain K; Beeke C; Price TJ; Townsend AR; Padbury R; Roder D; Young GP; Richards A; Karapetis CS
Cancer; 2013 Feb; 119(4):722-8. PubMed ID: 22990939
[TBL] [Abstract][Full Text] [Related]
19. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
[TBL] [Abstract][Full Text] [Related]
20. Left Versus Right: Does Location Matter for Refractory Metastatic Colorectal Cancer Patients in Phase 1 Clinical Trials?
Arora SP; Ketchum NS; Michalek J; Gelfond J; Mahalingam D
J Gastrointest Cancer; 2018 Sep; 49(3):283-287. PubMed ID: 28432610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
